Home » Topics » Regulatory

Regulatory
RSS

FDA approves Dupixent as add-on maintenance therapy for asthma

Oct. 22, 2018

No Comments

FDA approves Talzenna for germline BRCA-mutated HER2-negative breast cancer

Oct. 17, 2018

No Comments

FDA approves Yutiq for chronic noninfectious posterior segment uveitis

Oct. 15, 2018

No Comments

Revcovi approved in U.S. for ADA-SCID

Oct. 8, 2018

No Comments

FDA approves Nuzyra for CABP and ABSSSI

Oct. 3, 2018

No Comments

FDA approves Seysara for acne

Oct. 3, 2018

No Comments

FDA grants accelerated approval to Arikayce for MAC lung disease

Oct. 1, 2018

No Comments

FDA approves Libtayo for cutaneous squamous cell carcinoma

Oct. 1, 2018

No Comments

FDA approves Fycompa for partial-onset seizures in pediatric patients

Oct. 1, 2018

No Comments

Sanwa Kagaku Kenkyusho obtains approval for Metoana in Japan

Oct. 1, 2018

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Regulatory
RSS

FDA approves Dupixent as add-on maintenance therapy for asthma

FDA approves Talzenna for germline BRCA-mutated HER2-negative breast cancer

FDA approves Yutiq for chronic noninfectious posterior segment uveitis

Revcovi approved in U.S. for ADA-SCID

FDA approves Nuzyra for CABP and ABSSSI

FDA approves Seysara for acne

FDA grants accelerated approval to Arikayce for MAC lung disease

FDA approves Libtayo for cutaneous squamous cell carcinoma

FDA approves Fycompa for partial-onset seizures in pediatric patients

Sanwa Kagaku Kenkyusho obtains approval for Metoana in Japan

Today's news in brief

Today's news in brief

STAT6 stat sig? Kaken, J&J $1.2B-plus deal adds oomph to space

Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance

Australia’s Celosia heads toward clinic with gene therapy for ALS

Regulatory RSS

Regulatory
RSS